SWIXX BioPharma
Entry
2021
Hold
5yr
Exit
2026
Who owns SWIXX BioPharma?
SWIXX BioPharma is a Pharma company based in Europe, now owned by SK Capital / Bain Capital Life Sciences, which acquired it in 2026 from Merieux Equity Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
Secondary
Buyer
SK Capital / Bain Capital Life Sciences
Exit Year
2026
More from Mérieux Participations 3
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns SWIXX BioPharma?
SWIXX BioPharma is now owned by SK Capital / Bain Capital Life Sciences, which acquired it in 2026 from Merieux Equity Partners.
When did SK Capital / Bain Capital Life Sciences acquire SWIXX BioPharma?
SK Capital / Bain Capital Life Sciences acquired SWIXX BioPharma in 2026, buying from Merieux Equity Partners.
Who did SWIXX BioPharma sell to?
Merieux Equity Partners sold SWIXX BioPharma to SK Capital / Bain Capital Life Sciences in 2026 (Secondary).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue